Fluiconnecto India Private Limited faces a ₹35 lakh penalty from MCA for violating Section 203 of the Companies Act due to delayed company secretary appointments. Analysis and implications.
Read how Pandey Traders successfully appealed a GST ruling, classifying their product under Ch-2401 of GST Tariff, based on specific processes as outlined in Explanatory Note.
he case involves the violation of Section 118(1) of the Companies Act, 2013, which mandates that companies must prepare and sign minutes of general meetings, resolutions passed by postal ballot, and meetings of the Board of Directors or committees of the Board in a prescribed manner.
The Ministry of Civil Aviation has introduced the Aircraft (Security) Rules, 2023 to enhance civil aviation security in line with international conventions. These rules cover a wide range of aspects, including roles, responsibilities, and security measures. Let’s delve into a comprehensive analysis of each rule: Rule 1: Short title and commencement – These rules are […]
Explore the Domestic Gas Stoves for use with Piped Natural Gas (Quality Control) Order 2023 issued by the Ministry of Commerce and Industry, its standards, implications, and enforcement
Learn about Unique Disability Identification (UDID) Scheme for children below 18 years with disabilities. Explore Aadhaar integration, benefits, and implementation details.
Explore Unique Disability Identification (UDID) Scheme under Ministry of Social Justice and Empowerment. Learn about Aadhaar integration, benefits, and implementation.
Circular 20/2023-Customs authorizes 715 Booking Post Offices for electronic export declaration, as per Postal Export (Electronic Declaration and Processing) Regulations, 2022. Check the list of authorized offices.
SEBI mandates Foreign Portfolio Investors (FPIs) to conduct 10% of their secondary market trades in Corporate Bonds through the RFQ platform from October 2023. Read the circular for details.
DGFT extends the deadline for the Track and Trace system for exported drug formulations to February 1, 2024, for both SSI and non-SSI drugs.
